Risk factors
Natera (NTRA) risk factors
Item 1A of every Natera, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors54 risks2 new5 reworded
FDA's LDT rule was vacated and rescinded, leaving future regulation of Natera's genetic tests uncertain.
Filed Feb 27, 2026 - FY2024 10-K risk factors57 risks
Revenue is concentrated in Panorama, Horizon, and Signatera, which together drive most revenue and remain central to future growth.
Filed Feb 28, 2025